Letter Sequence Other |
|---|
|
|
MONTHYEARML21035A0742021-01-29029 January 2021
Framatome, Inc. Request for Review and Approval of ANP-10353P, Revision 0, Increased Enrichment for PWRs
Project stage: Request
ML21061A2132021-03-0202 March 2021
Acceptance for Framatome Topical Report ANP-10353P - Increased Enrichment for PWRs
Project stage: Acceptance Review
ML21217A1012021-08-10010 August 2021
September 13, 2021, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10353, Revision 0, Increased Enrichment for PWRs
Project stage: Other
ML21258A3402021-09-21021 September 2021
Letter-Request for Additional Information Regarding Framatome Topical Report, ANP-10353P, Revision 0, Increased Enrichment for PWRs (Pressurized Water Reactors)
Project stage: RAI
ML21305A0322021-11-0303 November 2021
Report for September 13, 2021, Regulatory Audit Regarding Framatome Inc. Topical Report, ANP-10353P, Revision 0, Increased Enrichment for PWRs
Project stage: Other
PMNS20220371, Closed Meeting Between the U.S. Nuclear Regulatory Commission (NRC) and Framatome Inc. to Discuss Topical Report ANP-10353P, Revision 0 - Increased Enrichment for Pressurized Water Reactors (Pwrs)2022-04-0808 April 2022
Closed Meeting Between the U.S. Nuclear Regulatory Commission (NRC) and Framatome Inc. to Discuss Topical Report ANP-10353P, Revision 0 - Increased Enrichment for Pressurized Water Reactors (Pwrs)
Project stage: Request
ML22129A0032022-05-31031 May 2022
Letter - August 17, 2022, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10353P, Revision 0, Increased Enrichment for PWRs
Project stage: Other
ML22137A2712022-06-0101 June 2022
June 13-17, 2022, Audit Plan for Framatome Inc. TR, ANP-10311P-A, Rev. 1, Supplement 1P, Rev. 0, Cobra-FLX: ORFEO-HMP Critical Heat Flux Correlation and EMF-2310, Rev. 1, Supplement 2P, Rev. 0 (Epids L-2021-TOP-0004 & L-2022-TOP-0008)
Project stage: Other
ML22158A1472022-06-14014 June 2022
NRCs Revised Schedule for the Review of Framatomes Topical Reports, ANP-10353P, Rev. 0, Increased Enrichment for Pwrs and ANP-10340P, Rev. 0, Suppl. 1, Rev. 0, Incorporation of Chromia-Doped Fuel Properties in Framatome PWR Methods
Project stage: Approval
ML22252A2522022-09-15015 September 2022
Report Regarding August 17, 2022, Regulatory Audit for Framatome Inc. Topical Report, ANP-10353P, Revision 0, Increased Enrichment for PWRs - Letter -
Project stage: Other
ML22353A6042022-12-22022 December 2022
Audit Report Regarding Framatome TR, ANP-10311P-A, Rev. 1, Supplement 1P, Rev. 0, COBRA-FLX: ORFEO-HMP CHF Correlation & EMF-2310, Rev. 1, Supplement 2P, Rev. 0, SRP Chpt. 15 Non-LOCA Methodology for PWR (EPIDs L-2021-TOP-0004 & L-2022-TOP-
Project stage: Other
ML23023A2662023-01-26026 January 2023
Withholding Determination Regarding Request for Comment on Draft Safety Evaluation for ANP-10353P, Revision 0, Increased Enrichment for PWRs (EPID L-2021-TOP-0004) - Transmittal
Project stage: Draft Approval
ML23023A2732023-01-26026 January 2023
Withholding Determination Regarding Response to Request for Comment on Draft Safety Evaluation for Framatome Topical Report, ANP-10353P, Revision 0, Increased Enrichment for PWRs (EPID L-2021-TOP-0004) - Form 897
Project stage: Draft Approval
ML23053A0532023-03-22022 March 2023
Final Safety Evaluation for Framatome Topical Report ANP-10353P, Revision 0, Increased Enrichment for PWRs (Letter)
Project stage: Approval
ML23165A1902023-06-16016 June 2023
Withholding Determination for Publication of Approved Framatome Topical Report, ANP-10353P-A, Revision 0, Increased Enrichment for PWRs (Form 897)
Project stage: Other
ML23165A1882023-06-16016 June 2023
Withholding Determination for Publication of Approved Framatome Topical Report, ANP-10353P-A, Revision 0, Increased Enrichment for PWRs (EPID L-2021-TOP-0004) (Transmittal)
Project stage: Other
ML23167A0022023-06-28028 June 2023
Verification for Publication of Approved Framatome Topical Report, ANP-10353P-A, Revision 0, Increased Enrichment for PWRs
Project stage: Other
ML23167A0032023-06-28028 June 2023
Verification for Publication of Approved Framatome Topical Report, ANP-10353P-A, Revision 0, Increased Enrichment for PWRs EPID L-2021-TOP-0004
Project stage: Other
2022-05-31
[Table View] |
Text
OFFICIAL USE ONLY - PROPRIETARY INFORMATION OFFICIAL USE ONLY - PROPRIETARY INFORMATION NOTICE: The enclosure to this transmittal letter has proprietary information, once this letter is separated from the enclosure it is decontrolled.
May 31, 2022 Mr. Gary Peters, Director Licensing and Regulatory Affairs Framatome Inc.
3315 Old Forest Road Lynchburg, VA 24501
SUBJECT:
AUGUST 17, 2022, REGULATORY AUDIT PLAN FOR FRAMATOME INC.
TOPICAL REPORT, ANP-10353P, REVISION 0, INCREASED ENRICHMENT FOR PWRs (EPID L-2021-TOP-0004)
Dear Mr. Peters:
By letter dated January 29, 2021 (Agencywide Documents Access and Management System (ADAMS) Accession No. ML21035A074), Framatome, Inc. (Framatome) submitted Topical Report (TR) ANP-10353P, Revision 0, Increased Enrichment for [Pressurized Water Reactors]
PWRs (ADAMS Package No. ML21035A073), to the U.S. Nuclear Regulatory Commission (NRC) for review and approval for licensing applications. Framatome states in part that ANP-10353P, Revision 0, addresses the codes and methods used to perform neutronics analyses, thermal hydraulic analyses, non-loss-of-coolant accident (non-LOCA) analyses, loss-of-coolant accident (LOCA) analyses, and thermal-mechanical fuel evaluations with respect to applicability to fuel with enrichment greater than 5 weight-percent Uranium-235.
The NRC staff technical review of this TR is ongoing. The NRC staff will perform a virtual regulatory audit on August 17, 2022, via Microsoft Teams. This audit was re-scheduled from May 25, 2022, per Framatomes request. The NRC staff determined that this regulatory audit is needed to facilitate the review. A previous audit was held on September 13, 2021 (ADAMS Accession No. ML21305A032). Enclosed for your information is a copy of the proprietary audit plan that the NRC staff will follow.
OFFICIAL USE ONLY - PROPRIETARY INFORMATION OFFICIAL USE ONLY - PROPRIETARY INFORMATION Please contact Ngola Otto at 301-415-6695 or via e-mail at Ngola.Otto@nrc.gov with any questions you may have regarding this letter.
Sincerely,
/RA/
Richard Chang, Chief Licensing Projects Branch Division of Operating Reactor Licensing Office of Nuclear Reactor Regulation Docket No. 99902041
Enclosure:
Audit Plan (Proprietary)
ML22129A003 (Letter); ML22129A002 (Audit Plan)
OFFICE NRR/DORL/LLPB NRR/DORL/LLPB NRR/DSS/SFNB NRR/DORL/LLPB NRR/DORL/LLPB NAME NOtto DHarrison RLukes RChang NOtto DATE 05/9/2022 05/25/2022 05/16/2022 05/26/2022 05/31/2022